Kemuning (Murraya paniculata)

Kemuning (Murraya paniculata) contains carbazole alkaloids like murrayafoline A that exhibit anti-diabetic and antimicrobial properties. These compounds work by inhibiting α-glucosidase enzyme activity and disrupting bacterial cell wall synthesis.

Category: Southeast Asian Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Kemuning (Murraya paniculata) — Hermetica Encyclopedia

Origin & History

Kemuning (Murraya paniculata) is a medicinal shrub from the Rutaceae family native to tropical and subtropical Asia, including India, Southeast Asia, and the Philippines. The plant's leaves, flowers, and aerial parts are extracted using methods such as acetone, methanol, or steam distillation for essential oils, yielding compounds including coumarins, flavonoids, indole alkaloids, and volatile oils.

Historical & Cultural Context

Murraya paniculata has been used in Southeast Asian and Philippine folk medicine for treating diarrhea, asthma, hypertension, and as an antifertility agent. The plant is particularly prominent in Indonesian jamu and traditional Asian medicine systems, though the exact duration of historical use is not specified.

Health Benefits

• Anti-diabetic activity demonstrated in preclinical models (animal studies only)
• Antimicrobial effects against bacteria and fungi shown in laboratory studies
• Gastroprotective properties observed in animal models
• Potential anticancer activity demonstrated in cell culture studies
• Traditional use for respiratory conditions like asthma (historical evidence only)

How It Works

Kemuning's carbazole alkaloids, particularly murrayafoline A and mahanimbine, inhibit α-glucosidase and α-amylase enzymes to reduce glucose absorption. The antimicrobial activity occurs through disruption of bacterial peptidoglycan synthesis and fungal ergosterol production. Gastroprotective effects involve prostaglandin E2 enhancement and reduction of gastric acid secretion.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on Murraya paniculata. All available research is limited to preclinical studies using in vitro and animal models, with no PubMed PMIDs for human studies provided in the literature.

Clinical Summary

Current evidence for Kemuning is limited to preclinical studies with no human clinical trials available. Animal studies using 200-400 mg/kg doses showed 40-60% reduction in blood glucose levels in diabetic rats. Laboratory antimicrobial testing demonstrated minimum inhibitory concentrations of 125-250 μg/mL against various bacterial strains. Cell culture studies indicated potential anticancer activity, but this requires extensive further research before any clinical relevance can be established.

Nutritional Profile

{"macronutrients": {"protein": "Not significant", "fiber": "Not significant"}, "micronutrients": {"vitamin_C": "Trace amounts", "calcium": "Trace amounts", "iron": "Trace amounts"}, "bioactive_compounds": {"murrayanol": "Present, specific concentration not well-documented", "murrayacine": "Present, specific concentration not well-documented", "coumarins": "Present, specific concentration not well-documented"}, "bioavailability_notes": "The bioactive compounds such as murrayanol and murrayacine have not been extensively studied for human bioavailability. Traditional uses suggest some level of efficacy, but scientific validation is limited."}

Preparation & Dosage

No clinically studied dosage ranges are available as human trials have not been conducted. Preclinical studies used various extracts without standardized dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other traditional jamu herbs, turmeric, ginger, green tea, citrus bioflavonoids

Safety & Interactions

Safety data for Kemuning supplementation in humans is insufficient due to lack of clinical studies. Traditional use suggests general tolerability, but potential side effects and optimal dosing remain unknown. The herb may theoretically interact with diabetes medications due to its glucose-lowering properties, requiring blood sugar monitoring. Pregnancy and breastfeeding safety has not been established, so use should be avoided during these periods.